Skip to content

Acute Effects of Thai Traditional Massage on Cerebrovascular Reactivity in Ischemic Stroke Patients

Acute Effects of Thai Traditional Massage on Cerebrovascular Reactivity in Ischemic Stroke Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02270294
Enrollment
14
Registered
2014-10-21
Start date
2014-10-01
Completion date
2016-08-03
Last updated
2018-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Keywords

Ischemic stroke, Thai traditional massage, Vascular function, Cerebral blood flow, Cerebrovascular reactivity

Brief summary

The investigators hypothesize that Acute Thai traditional massage will yield beneficial effects on cerebrovascular reactivity in ischemic stroke patients.

Interventions

Thai traditional massage treatment based on original Thai traditional massage at Wat Po was use in this study. The participants will be assigned to receive one time of Thai traditional massage one time. Thai traditional massage techniques consists of petrissage, friction, and passive stretching on head, neck, shoulders, arms, back and legs for 60 minutes.

OTHERNo massage

The participants will be asked to lie down in relaxant position on bed without sleep for 60 minutes.

Sponsors

Chulalongkorn University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. A single ischemic stroke with Middle cerebral artery (MCA) stenosis 2. Men or women age 50-80 years 3. Physician's approvals to participate the study 4. Stroke experienced at least 7 days of ischemic stroke onset and no more than 6 months before study enrollment 5. The modified rankin scale level is 2 or 3

Exclusion criteria

1. History of serious diseases * Musculoskeletal diseases (Chronic arthritis, Lower spondylosis/spondylolisthesis with radiculopathy, Spinal deformity, Cervical spondylosis, Rheumatoid arthritis) * Cardiovascular diseases (Poorly control hypertension, Heart disease class C and D) * Neurological disorders (Peripheral neuropathy, Parkinson) * Respiratory diseases (Chronic Obstructive Pulmonary Disease) * Brain disorders (Cardioembolic, Severe dementia, Alzheimer's disease) * Medical condition precluding taking Anticoagulant and Statin drug 2. Temporal window were not found

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in cerebrovascular reactivitybaseline, Post-test (immediately: 0 min after finish massage intervention, 60 min, 120 min, 24 Hrs.\- Cerebrovascular reactivity or cerebral CO2 reactivity test will be assessed using the ultrasound equipment (CX50, Philips, USA). Blood flow velocity (BFV) of the middle cerebral artery (MCA) will be measured during normocapnic, hypocapnic, and hypercapnic states. Subjects will be asked to wear nose clips and breathe only through a mouthpiece. Baseline (3 minutes) recordings will be taken during spontaneous breathing of room air and then subjects underwent 1 minute of maximal voluntary hyperventilation with a duty cycle of 1 second. The MCA-BFV will be recorded during the last 20 seconds of hyperventilation. After that, subjects will be asked to breathe air containing a mixture of 5 % CO2 and 21 % O2 balanced with nitrogen spontaneously for 3 minutes and the MCA-BFV will be recorded during the last minute of hypercapnia.

Secondary

MeasureTime frameDescription
Change from baseline in stress indicatorsBaseline, Post-test (immediately: 0 min after finish massage intervention)\- Serum cortisol will be measured with cortisol EIA kit (Enzo Life Science, Switzerland).
Change from baseline in Peripheral arterial stiffnessBaseline, Post-test (immediately: 0 min after finish massage intervention, 60 min, 120 min, 24 Hrs.\- Pulse wave velocity measurement will be assessed with MD6 bidirectional transcutaneous Doppler probe (Hokanson, Bellevue, WA, USA). All subjects will be monitored with an EKG and PWV measurements in the computer and used as timing markers for PWV identification.
Change from baseline in blood chemistrybaseline, Post-test (immediately: 0 min after finish massage intervention)* Nitric oxide (NO) will be measured in plasma samples with Colorimetric nitric oxide assay kit (Biovision, USA). * Beta-endorphin will be measured in serum samples with the commercial assay kit (Beta-endorphin \[bEP\] BioAssay ELISA kit \[Human\], US Biological Life Science). * Malondialdehyde (MDA) will be determined using thiobarbituric acid reaction.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026